Abstract:BACKGROUND:Copy number alterations (CNA) and loss of heterozygosity (LOH) represent a large proportion of genetic structural variations of cancer genomes. These aberrations are continuously accumulated during the procedure of clonal evolution and patterned by phylogenetic branching. This invariably results in the emergence of multiple cell populations with distinct complement of mutational landscapes in tumor sample. With the advent of next-generation sequencing technology, inference of subclonal populations has become one of the focused interests in cancer-associated studies, and is usually based on the assessment of combinations of somatic single-nucleotide variations (SNV), CNA and LOH. However, cancer samples often have several inherent issues, such as contamination of normal stroma, tumor aneuploidy and intra-tumor heterogeneity. Addressing these critical issues is imperative for accurate profiling of clonal architecture.METHODS:We present CLImAT-HET, a computational method designed for capturing clonal diversity in the CNA/LOH dimensions by taking into account the intra-tumor heterogeneity issue, in the case where a reference or matched normal sample is absent. The algorithm quantitatively represents the clonal identification problem using a factorial hidden Markov model, and takes an integrated analysis of read counts and allele frequency data. It is able to infer subclonal CNA and LOH events as well as the fraction of cells harboring each event.RESULTS:The results on simulated datasets indicate that CLImAT-HET has high power to identify CNA/LOH segments, it achieves an average accuracy of 0.87. It can also accurately infer proportion of each clonal population with an overall Pearson correlation coefficient of 0.99 and a mean absolute error of 0.02. CLImAT-HET shows significant advantages when compared with other existing methods. Application of CLImAT-HET to 5 primary triple negative breast cancer samples demonstrates its ability to capture clonal diversity in the CAN/LOH dimensions. It detects two clonal populations in one sample, and three clonal populations in one other sample.CONCLUSIONS:CLImAT-HET, a novel algorithm is introduced to infer CNA/LOH segments from heterogeneous tumor samples. We demonstrate CLImAT-HET's ability to accurately recover clonal compositions using tumor WGS data without a match normal sample.

Identification of Genomic Aberrations in Cancer Subclones from Heterogeneous Tumor Samples

A novel HMM for analyzing chromosomal aberrations in heterogeneous tumor samples

CLImAT-HET: Detecting Subclonal Copy Number Alterations and Loss of Heterozygosity in Heterogeneous Tumor Samples from Whole-Genome Sequencing Data.

Clonecna: Detecting Subclonal Somatic Copy Number Alterations in Heterogeneous Tumor Samples from Whole-Exome Sequencing Data

Genome-Wide Identification of Somatic Aberrations from Paired Normal-Tumor Samples

A Novel CNA/LOH Detection Algorithm Using Normal-Tumor SNP-Array Data

Analyzing Tumor Heterogeneity by Incorporating Long-Range Mutational Influences and Multiple Sample Data into Heterogeneity Factorial Hidden Markov Model

Clustering of Transcriptomic Data for the Identification of Cancer Subtypes

Integrated Modeling of GC-Content, Mappability, Tumor Impurity and Aneuploidy for Accurate Detection of Genomic Aberrations.

Copy Number Aberrations from Affymetrix SNP 6.0 Genotyping Data-How Accurate Are Commonly Used Prediction Approaches?

Reconstructing tumor clonal heterogeneity and evolutionary relationships based on tumor DNA sequencing data

A Bayesian framework to study tumor subclone-specific expression by combining bulk DNA and single-cell RNA sequencing data

A feasible roadmap to identifying significant intercellular genomic heterogeneity in deep sequencing data

A CNV Computational Model for Clonal Origin Analysis of Synchronous Multifocal Hepatobiliary and Pancreatic Tumors.

Robust analysis of allele-specific copy number alterations from scRNA-seq data with XClone

Phylogeny-based tumor subclone identification using a Bayesian feature allocation model

CLImAT: Accurate Detection of Copy Number Alteration and Loss of Heterozygosity in Impure and Aneuploid Tumor Samples Using Whole-Genome Sequencing Data

HaplotypeCN: Copy Number Haplotype Inference with Hidden Markov Model and Localized Haplotype Clustering

Major Copy Proportion Analysis of Tumor Samples Using Snp Arrays

Combining chromosomal arm status and significantly aberrant genomic locations reveals new cancer subtypes

A statistical learning method for simultaneous copy number estimation and subclone clustering with single-cell sequencing data